Related Experiment Video
Updated: May 31, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Immunohistochemistry of melanocytic proliferations
Victor G Prieto1, Christopher R Shea
1Department of Pathology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. vprieto@mdanderson.org
Context:
Histologic analysis allows accurate classification of most melanocytic lesions as benign or malignant. Only in a minority of lesions is it necessary to use other techniques as an aid in the diagnosis. Among them, most authors recommend immunohistochemistry.
Objective:
To describe how to apply immunohistochemistry to particular differential diagnoses and the potential pitfalls.
Data Sources:
Personal experience and review of literature.
Conclusions:
There is no single marker, or combination thereof, that establishes an unequivocal diagnosis of melanoma or nevus. Thus it is necessary to carefully analyze the pattern of expression (patchy versus diffuse) and localization (maturation) in the context of morphologic standard features.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Immunocytochemistry and Immunohistochemistry
These...

